Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by FRESENIUS KABI USA
FDA Drug Application 019627 by FRESENIUS KABI USA
Application Number
019627
Application Type
New Drug Application
Sponsor Applicant
FRESENIUS KABI USA
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New molecular entity (NME)
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
10/2/1989
N
16789
000
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109357.htm
6/18/2007
AP
0
1/18/1991
SCP
AP
0
12/31/1991
SE1
21572
002
http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019627_S002_Diprivan.pdf
1/12/2009
AP
0
1/18/1991
SLR
AP
0
1/18/1991
SLR
AP
0
1/18/1991
SLR
AP
0
3/9/1993
SCS
AP
0
5/9/1994
SLR
AP
0
3/8/1993
SE1
AP
0
2/25/1992
SCM
AP
0
12/11/1992
SCM
AP
0
10/26/1993
SE1
AP
0
10/26/1993
SLR
AP
0
9/7/1994
SLR
AP
0
2/24/1995
SCP
AP
0
5/6/1994
SCS
AP
0
4/21/1995
SLR
AP
0
7/31/1995
SCP
AP
0
6/11/1996
SCF
17196
027
http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/019627_S027_Diprivan_APPROVAL_PACKAGE.pdf
7/9/2007
AP
0
9/11/1997
SCS
AP
0
4/29/1999
SLR
AP
0
9/29/1998
SCM
AP
0
2/4/1999
SCM
AP
0
4/29/1999
SCM
AP
0
2/23/2001
SE5
1314
035
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/19627S35LTR.pdf
2/23/2001
AP
0
2/23/2001
SE5
1315
035
http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/19627S35LBL.pdf
2/23/2001
AP
0
2/23/2001
SE5
17252
035
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/019627_S035_DiprivanTOC.cfm
7/9/2007
AP
0
12/7/1999
SCM
AP
0
2/7/2000
SCP
AP
0
10/27/2000
SCM
AP
0
9/3/2002
SCS
AP
0
2/8/2007
SLR
15820
045
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/019627s045ltr.pdf
2/12/2007
AP
0
2/8/2007
SLR
15855
045
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019627s045lbl.pdf
2/21/2007
AP
0
2/8/2007
SLR
21573
045
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/019627_S045_DIPRIVAN.pdf
1/12/2009
AP
0
4/14/2008
SLR
19641
046
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/019627s046ltr.pdf
4/16/2008
AP
0
4/14/2008
SLR
19708
046
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019627s046lbl.pdf
4/23/2008
AP
0
5/5/2014
SCM
AP
0
7/9/2013
SCM
37104
060
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/019627Orig1s060ltr.pdf
9/17/2013
AP
0
7/9/2013
SCM
37189
060
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/019627Orig1s060.pdf
9/24/2013
AP
0
7/9/2013
SCM
38383
060
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019627s60lbl.pdf
1/28/2014
AP
0
6/8/2014
SCM
39477
062
http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019627s062lbl.pdf
6/10/2014
AP
0
4/17/2015
SCM
Back to FDA Applications sponsored by FRESENIUS KABI USA